Category: Substance Use Disorders

Effect of orange peel carbon dot immobilized titanium-based metal-organic framework on buckwheat starch/chitosan films and their preservation performance for grapes

Food Res Int. 2026 Nov 1;243(Pt 2):120390. doi: 10.1016/j.foodres.2026.120390. Epub 2026 Aug 20.ABSTRACTThe growing demand for sustainable and active food-packaging materials has encouraged the development...

RAISR4D Substance Use Disorders

Mental health disorders and risk of solitary confinement among incarcerated individuals: a nationwide longitudinal cohort study from Norway

BMJ Ment Health. 2026 Sep 7;29(1):e302849. doi: 10.1136/bmjment-2026-302849.ABSTRACTBACKGROUND: Solitary confinement is extensively used in prisons, constituting a risk of deteriorating health. However, its associations with...

RAISR4D Substance Use Disorders

Online Presentation of No-, Low- and Full-Strength Alcohol in Three New Zealand Online Alcohol Retailers: Implications for Harm-Reduction Policy

Drug Alcohol Rev. 2026 Sep;45(6):e70240. doi: 10.1111/dar.70240.ABSTRACTINTRODUCTION: The availability of no- and low-alcohol (NOLO) products could lead to reduced consumption of full-strength alcohol, although concerns...

RAISR4D Substance Use Disorders

Linking emergency department opioid prescribing with ongoing opioid use: a statewide data linkage study

Aust Health Rev. 2026 Oct 1;50(4):AH26056. doi: 10.1071/AH26056.ABSTRACTOBJECTIVE: Chronic opioid use can develop in previously opioid-naïve patients following an emergency department (ED) or hospital admission;...

RAISR4D Substance Use Disorders

Protective effects of central leptin on whole-body energy homeostasis following acute olanzapine exposure

Neuropharmacology. 2026 Sep 7:111180. doi: 10.1016/j.neuropharm.2026.111180. Online ahead of print.ABSTRACTAntipsychotics represent mainstay treatment of schizophrenia and are also prescribed on- and off-label in other severe...

RAISR4D Substance Use Disorders

Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

Lancet Public Health. 2026 Sep 7:S2468-2667(26)00168-4. doi: 10.1016/S2468-2667(26)00168-4. Online ahead of print.ABSTRACTBACKGROUND: Second-hand smoke (SHS) exposure remains a major source of morbidity and mortality among...

RAISR4D Substance Use Disorders

Facility, community, and state-level correlates of overdose education and naloxone provision in substance use treatment facilities in the United States

Addict Behav. 2026 Aug 22;184:108837. doi: 10.1016/j.addbeh.2026.108837. Online ahead of print.ABSTRACTBACKGROUND: This study examined which characteristics of substance use disorder (SUD) treatment facilities and their...

RAISR4D Substance Use Disorders

Interventions to Improve Outpatient Follow-up for Hospitalized Patients With Alcohol Use Disorder : A Systematic Review

Ann Intern Med. 2026 Sep 8. doi: 10.7326/ANNALS-26-01312. Online ahead of print.ABSTRACTBACKGROUND: Hospitalizations for alcohol use disorder (AUD) are common and morbid. Outpatient follow-up after...

RAISR4D Substance Use Disorders

07/09/2026

Assessing Attitudes Toward Marijuana Legalization in Türkiye: An Analysis of Key Stakeholders

Subst Use Misuse. 2026 Sep 6:1-10. doi: 10.1080/10826084.2026.2726534. Online ahead of print.ABSTRACTBACKGROUND: Despite global liberalization trends increasingly supporting the legalization of marijuana, attitudes in countries...

RAISR4D Substance Use Disorders

06/09/2026

Motivational interviewing as a clinical decision-support skill in time-limited practice

Patient Educ Couns. 2026 Sep 2;153:109812. doi: 10.1016/j.pec.2026.109812. Online ahead of print.ABSTRACTOBJECTIVES: To reconceptualise motivational interviewing (MI) as a clinical decision-support skill for time-limited healthcare...

RAISR4D Substance Use Disorders

06/09/2026

The impact of language-related immigration policies on immigrant mental health care utilization

Econ Hum Biol. 2026 Aug 28;63:101642. doi: 10.1016/j.ehb.2026.101642. Online ahead of print.ABSTRACTEconomic immigrants are selected into Canada using a point system, which accounts for immigrants'...

RAISR4D Substance Use Disorders

Elucidating mechanism of Biejia-Ruangan Compound Tablets against alcoholic liver disease through gut-liver axis using integrated multi-omics

Zhongguo Zhong Yao Za Zhi. 2026 Aug;51(15):4401-4409. doi: 10.19540/j.cnki.cjcmm.20260421.801.ABSTRACTBased on the gut-liver axis, this study integrated multi-omics and network pharmacology strategies to explore the mechanism...

RAISR4D Substance Use Disorders

Research progress on mechanisms of TCM and its active components in treatment of oligoasthenozoospermia

Zhongguo Zhong Yao Za Zhi. 2026 Aug;51(15):4293-4302. doi: 10.19540/j.cnki.cjcmm.20260428.501.ABSTRACTOligoasthenozoospermia(OAS) is one of the major types of male infertility. Its pathogenesis involves multiple factors, including oxidative...

RAISR4D Substance Use Disorders

Gender Differences in Sexually Active Life Expectancy in France

Perspect Sex Reprod Health. 2026 Sep 3. doi: 10.1111/psrh.70076. Online ahead of print.ABSTRACTINTRODUCTION: A life course perspective on sexual activity is gaining attention due to...

RAISR4D Substance Use Disorders

Corrigendum to “Brief mindfulness intervention for adults with cannabis use disorder: A randomised clinical trial” [Drug Alcohol Depend. 277 (2025) 112909]

Drug Alcohol Depend. 2026 Sep 3:113332. doi: 10.1016/j.drugalcdep.2026.113332. Online ahead of print.NO ABSTRACTPMID:42692868 | DOI:10.1016/j.drugalcdep.2026.113332

RAISR4D Substance Use Disorders

Outpatient Direct Initiation of Injectable Buprenorphine From Methadone: A Case Series

J Addict Med. 2026 Sep 3. doi: 10.1097/ADM.0000000000001770. Online ahead of print.ABSTRACTOBJECTIVES: Published protocols for directly initiating injectable buprenorphine from full opioid agonists ("direct-to-inject" or...

RAISR4D Substance Use Disorders

Impact of Addiction Consult Service on Alcohol Use Disorder Medications and Postdischarge Outcomes

J Addict Med. 2026 Sep 3. doi: 10.1097/ADM.0000000000001762. Online ahead of print.ABSTRACTOBJECTIVES: This study aims to evaluate the association between Addiction Consult Service (ACS) involvement...

RAISR4D Substance Use Disorders

Methamphetamine-associated cardiovascular conditions in general practice: Screening, management and harm reduction

Aust J Gen Pract. 2026 Sep;55(9):630-632. doi: 10.31128/AJGP-07-25-7758.ABSTRACTBACKGROUND: Methamphetamine use is a prevalent but under-recognised cause of acute and chronic cardiovascular conditions. Deaths from methamphetamine-associated...

RAISR4D Substance Use Disorders

Management of patients using anabolic androgenic steroids and other performance and image enhancing drugs (including peptides): A harm reduction approach

Aust J Gen Pract. 2026 Sep;55(9):619-624. doi: 10.31128/AJGP-05-26-8142.ABSTRACTBACKGROUND: Performance and image enhancing drugs (PIEDs) include a diverse range of substances used to improve physical performance,...

RAISR4D Substance Use Disorders

Balancing care with compliance: Medicolegal issues for general practitioners treating attention deficit hyperactivity disorder

Aust J Gen Pract. 2026 Sep;55(9):595-601. doi: 10.31128/AJGP-01-26-7995.ABSTRACTBACKGROUND: As demand for attention deficit hyperactivity disorder (ADHD) treatments increases, Australian governments are relaxing the requirements for...

RAISR4D Substance Use Disorders

Pharmacokinetic properties of the clinical drug candidate PRI-002 with regard to genotype, sex, age, dose-dependence and food effects in mice

Eur J Pharm Sci. 2026 Sep 3:107649. doi: 10.1016/j.ejps.2026.107649. Online ahead of print.ABSTRACTThe d-enantiomeric peptide RD2 (named Contraloid or PRI-002 in clinical trials) was developed...

RAISR4D Substance Use Disorders

Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer’s Disease

J Am Med Dir Assoc. 2026 Sep 3;27(11):106481. doi: 10.1016/j.jamda.2026.106481. Online ahead of print.ABSTRACTOBJECTIVES: To examine treatment duration of oral and transdermal cholinesterase inhibitor formulations...

RAISR4D Substance Use Disorders

Addressing fusiform gyrus dysfunction in schizophrenia, theory of mind, and implications for antipsychotics’ response and resistance: A systematic review and critical appraisal

Neurosci Biobehav Rev. 2026 Sep 3;191:106938. doi: 10.1016/j.neubiorev.2026.106938. Online ahead of print.ABSTRACTBACKGROUND: The Fusiform Gyrus (FG), a brain region relevant for the interaction between cognitive...

RAISR4D Substance Use Disorders

Postpartum obsessive compulsive symptom onset: Modelling vulnerability longitudinally

J Anxiety Disord. 2026 Aug 28;123:103220. doi: 10.1016/j.janxdis.2026.103220. Online ahead of print.ABSTRACTBACKGROUND: The perinatal period represents risk for the development of postpartum obsessive-compulsive symptoms (POCS)...

RAISR4D Substance Use Disorders

03/09/2026

Appropriate Monitoring, Documentation, and Related Equipment for the Modern Sedation Office

Dent Clin North Am. 2026 Oct;70(4):739-748. doi: 10.1016/j.cden.2026.05.001. Epub 2026 Jul 1.ABSTRACTThis article outlines essential guidelines and protocols for safe outpatient sedation practice. It emphasizes...

RAISR4D Substance Use Disorders

03/09/2026

Exploring interneuron conduction time in the motor cortex and the link to motor function in individuals with chronic stroke

J Neurophysiol. 2026 Sep 2. doi: 10.1152/jn.00103.2026. Online ahead of print.ABSTRACTInterneurons in the motor cortex (M1) contribute to key motor functions, which are often altered...

RAISR4D Substance Use Disorders

Répondre par une action territoriale et avec des patients-partenaires à un défi de santé lié aux addictions

Sante Publique. 2026;38(HS1):181-199. doi: 10.3917/spub.hs1.2026.0181.ABSTRACTINTRODUCTION: In a context in which institutions recommend addressing health challenges through patient engagement, we have chosen to develop and pilot...

RAISR4D Substance Use Disorders

The ARISE (Autism Research Initiatives for Suicidality and Empowerment) Project: A study protocol for a modified James Lind Alliance priority-setting process determining research priorities for suicidality in autistic youth

BMJ Open. 2026 Aug 31;16(8):e115813. doi: 10.1136/bmjopen-2025-115813.ABSTRACTINTRODUCTION: Autistic children and adolescents (herein, youth) are at 3.5 times greater risk of suicide attempts and deaths than...

RAISR4D Substance Use Disorders

Synergy of KRAS-inhibitor Daraxonrasib Combined With Recombinant Methioninase on Pancreatic-cancer Cells But Not Normal Cells

Anticancer Res. 2026 Sep;46(9):4859-4865. doi: 10.21873/anticanres.18338.ABSTRACTBACKGROUND/AIM: Approximately 30% of all cancers have mutations in the KRAS proto-oncogene, GTPase (KRAS), and approximately 88% of pancreatic cancer...

RAISR4D Substance Use Disorders

Eco-Friendly In-Situ Zwitterionization of Stent Metals with Phosphonic Sulfobetaine Copolymers for Durable Antibiofouling and Hemocompatibility

Langmuir. 2026 Aug 25;42(33):23931-23942. doi: 10.1021/acs.langmuir.6c02010.ABSTRACTAlthough stainless steel (SS) is widely used for cardiovascular stents, its surface is prone to undesirable biological interactions that contribute...

RAISR4D Substance Use Disorders

BLA astrocytes are associated with withdrawal somatic signs during high-dose naloxone-precipitated morphine withdrawal revealed by 3D-AI behavioral analysis

Neuropharmacology. 2026 Aug 31:111165. doi: 10.1016/j.neuropharm.2026.111165. Online ahead of print.ABSTRACTRelapse triggered by withdrawal memory is the important challenge in addiction therapy, with somatic withdrawal symptoms...

RAISR4D Substance Use Disorders

Cocaine-Induced interindividual variability in female rats: From behavior to gene expression

Neuropharmacology. 2026 Aug 31:111160. doi: 10.1016/j.neuropharm.2026.111160. Online ahead of print.ABSTRACTCocaine use disorder is marked by strong interindividual variability, yet the molecular determinants underlying vulnerability in...

RAISR4D Substance Use Disorders

Exposure Robustness by Design: a translational framework for oral drug product development

Drug Discov Today. 2026 Aug 31:104791. doi: 10.1016/j.drudis.2026.104791. Online ahead of print.ABSTRACTOral drug product development has traditionally been optimized around maximizing mean bioavailability in healthy...

RAISR4D Substance Use Disorders

Endogenous opioid dynamics in the dorsal striatum sculpt neural activity to promote goal-directed action

Cell. 2026 Aug 31:S0092-8674(26)00927-X. doi: 10.1016/j.cell.2026.07.058. Online ahead of print.ABSTRACTEndogenous neuropeptides are uniquely poised to regulate neuronal activity and behavior across multiple timescales. Traditional studies...

RAISR4D Substance Use Disorders

Redundancy-aware AI-guided discovery and experimental validation of antimicrobial peptides for infected wound treatment

Eur J Med Chem. 2026 Aug 31;319:119277. doi: 10.1016/j.ejmech.2026.119277. Online ahead of print.ABSTRACTArtificial intelligence (AI) is accelerating antimicrobial peptide (AMP) discovery, but prediction-centered workflows often...

RAISR4D Substance Use Disorders

Validation of the alcohol induced blackout measure-2 (ABOM-2) among young adults who experience blackout

Addict Behav. 2026 Aug 31;184:108844. doi: 10.1016/j.addbeh.2026.108844. Online ahead of print.ABSTRACTMemory loss from alcohol ("blackout") is common among young adults who drink and associated with...

RAISR4D Substance Use Disorders

Prevention of postpartum methamphetamine use with micronized progesterone trial (PROMPT): A pilot randomized controlled trial

Drug Alcohol Depend. 2026 Aug 27;287:113325. doi: 10.1016/j.drugalcdep.2026.113325. Online ahead of print.ABSTRACTOBJECTIVES: Methamphetamine use disorder (MUD) contributes to postpartum morbidity and mortality. Postpartum progesterone decline...

RAISR4D Substance Use Disorders

Integrating Use Frequency, Vaping, and Dependence to Characterize Nicotine-Cannabis Co-Use in Young Adults: A Latent Class Analysis

Nicotine Tob Res. 2026 Aug 31:ntag194. doi: 10.1093/ntr/ntag194. Online ahead of print.ABSTRACTINTRODUCTION: Tobacco and cannabis co-use is an increasingly complex public health challenge shaped by...

RAISR4D Substance Use Disorders

31/08/2026

Anger among Mental Healthcare Nurses in Japan: In the Context of Workplace Violence

Kurume Med J. 2026 Aug 31. doi: 10.2739/kurumemedj.MS7312001. Online ahead of print.ABSTRACTAnger may arise following harmful experiences such as violence, and managing anger may be...

RAISR4D Substance Use Disorders

31/08/2026

Hippocampal synaptic transmission and Ca2⁺ signaling are altered by the selective 5-HT2A receptor agonist, 25CN-NBOH

Neuroscience. 2026 Aug 30:S0306-4522(26)00591-9. doi: 10.1016/j.neuroscience.2026.08.049. Online ahead of print.ABSTRACTClassical psychedelics exert therapeutic effects on affective disorders, with serotonin 5-HT2A receptor activation thought to play...

RAISR4D Substance Use Disorders

31/08/2026

Incubation of cocaine craving is associated with reduced context-induced Fos expression in parvalbumin interneurons in the nucleus accumbens core of male rats

Neuroscience. 2026 Aug 30:S0306-4522(26)00590-7. doi: 10.1016/j.neuroscience.2026.08.047. Online ahead of print.ABSTRACTSubstance use disorder develops in a subset of individuals after repeated drug exposure and is characterized...

RAISR4D Substance Use Disorders

30/08/2026

The impact of cessation aids on sustained quitting and weight gain among adults with a quit attempt in the PATH study

Nicotine Tob Res. 2026 Aug 29:ntag189. doi: 10.1093/ntr/ntag189. Online ahead of print.ABSTRACTINTRODUCTION: This study aimed to compare cessation and weight gain among US adults in...

RAISR4D Substance Use Disorders

30/08/2026

Schisandra chinensis polysaccharide attenuates diabetic islet cell injury by promoting autophagy via suppression of the PI3K/AKT/mTOR signaling cascade

J Mol Histol. 2026 Aug 29;57(5):285. doi: 10.1007/s10735-026-10957-2.ABSTRACTBACKGROUND: Schisandra chinensis polysaccharide (SCP) has demonstrated antidiabetic properties in previous studies; however, the mechanisms underlying its regulation...

RAISR4D Substance Use Disorders

Discovery of Ro 41-0960, a Non-Steroidal Inhibitor of the Na+/K+-ATPase

ChemMedChem. 2026 Sep 14;21(17):e70442. doi: 10.1002/cmdc.70442.ABSTRACTThe Na+/K+-ATPase (NKA) is a central regulator of cardiac ion homeostasis and a validated target for heart failure. Yet, cardiotonic...

RAISR4D Substance Use Disorders

The Phosphatidylinositol 3-Kinase (PI3K) Inhibitor Inavolisib Has Breast-cancer Synergy Combined With Recombinant Methioninase But Not on Normal Cells

In Vivo. 2026 Sep-Oct;40(5):2663-2669. doi: 10.21873/invivo.14420.ABSTRACTBACKGROUND/AIM: The phosphatidylinositol 3-Kinase (PI3K) pathway is thought to be oncogenic in cancers when it is mutated at various sites....

RAISR4D Substance Use Disorders

Role of School Nurses in Preventing Digital Addiction and Promoting Health Among School-Age Adolescents

NASN Sch Nurse. 2026 Aug 28:1942602X261482095. doi: 10.1177/1942602X261482095. Online ahead of print.ABSTRACTExcessive digital technology use among adolescents has become an increasing public health concern, with...

RAISR4D Substance Use Disorders

International consensus recommendations for smoking cessation in type 2 diabetes from the DiaSmokeFree Working group

Diabetes Res Clin Pract. 2026 Aug 28:113528. doi: 10.1016/j.diabres.2026.113528. Online ahead of print.ABSTRACTAIMS: To provide evidence-based recommendations for integrating smoking cessation into the prevention and...

RAISR4D Substance Use Disorders

Stakeholder views on implementing a novel addiction screening and prevention tool in a hospital setting: A qualitative study

J Subst Use Addict Treat. 2026 Aug 28:210103. doi: 10.1016/j.josat.2026.210103. Online ahead of print.ABSTRACTINTRODUCTION: Current best practice is for primary care physicians (PCPs) to screen...

RAISR4D Substance Use Disorders

Ultra-sensitive dual-responsive Zn(II)-MOF fluorescent probe: Rapid recognition of cinoxacin and vitamin B₂ in artificial urine and saliva matrices

Spectrochim Acta A Mol Biomol Spectrosc. 2026 Aug 26;364(Pt 2):128657. doi: 10.1016/j.saa.2026.128657. Online ahead of print.ABSTRACTThis study successfully synthesized a new zinc-based metal-organic framework material...

RAISR4D Substance Use Disorders

Prevalence, determinants and trends of anabolic-androgenic steroid use among 93,437 high-school students: Repeated cross-sectional studies in Italy

Public Health. 2026 Aug 28;259:106470. doi: 10.1016/j.puhe.2026.106470. Online ahead of print.ABSTRACTOBJECTIVES: Limited information is available on anabolic-androgenic steroids (AAS) use among young people. This study...

RAISR4D Substance Use Disorders

TRPV4 promotes histamine receptor signaling in lymphatic endothelial cells

Cell Calcium. 2026 Aug 20;137:103184. doi: 10.1016/j.ceca.2026.103184. Online ahead of print.ABSTRACTBACKGROUND: The control of lymphatic permeability and flow is essential for homeostatic regulation of tissue...

RAISR4D Substance Use Disorders

A nicotinic-dopaminergic hybrid probe enhances D2-like autoreceptor-mediated inhibition of dopamine release

Biomed Pharmacother. 2026 Aug 28;203:119867. doi: 10.1016/j.biopha.2026.119867. Online ahead of print.ABSTRACTβ2-containing nicotinic acetylcholine receptors (nAChRs) and dopamine D2 receptors (D2Rs) cooperate to shape striatal dopamine...

RAISR4D Substance Use Disorders

Intentional substance exposures at school reported to United States poison centers, 2000-2024

Am J Emerg Med. 2026 Aug 22;110:197-209. doi: 10.1016/j.ajem.2026.08.031. Online ahead of print.ABSTRACTOBJECTIVE: The objective of this study was to investigate the characteristics and trends...

RAISR4D Substance Use Disorders

Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non-Small Cell Lung Cancer

Cancer Res Commun. 2026 Aug 28. doi: 10.1158/2767-9764.CRC-25-0829. Online ahead of print.ABSTRACTNon-small-cell lung cancer (NSCLC) is responsible for the majority of cancer-related mortality worldwide. Lung...

RAISR4D Substance Use Disorders

Implementing Prolonged Exposure Therapy in a Community Substance Use Treatment Program: A Qualitative Study

Drug Alcohol Rev. 2026 Sep;45(6):e70239. doi: 10.1111/dar.70239.ABSTRACTINTRODUCTION: Post-traumatic stress disorder (PTSD) commonly co-occurs with substance use disorders (SUD), yet few community-based SUD programs incorporate evidence-based...

RAISR4D Substance Use Disorders

Enhancement of 2-arachidonoylglycerol but not anandamide signaling in the ventral tegmental area selectively increases the choice to respond to reward-predictive incentive cues in male rats

Neuropharmacology. 2026 Aug 26:111154. doi: 10.1016/j.neuropharm.2026.111154. Online ahead of print.ABSTRACTMesolimbic endocannabinoid (eCB) signaling impacts reward-seeking behaviors that rely on incentive salience. We previously showed that...

RAISR4D Substance Use Disorders

Decreased accumbens-amygdala connectivity is associated with sleep improvement in late-life depression following mindfulness-based cognitive therapy

J Affect Disord. 2026 Aug 26:122433. doi: 10.1016/j.jad.2026.122433. Online ahead of print.ABSTRACTBACKGROUND: Mindfulness-based cognitive therapy (MBCT) may improve sleep in major depressive disorder. This secondary...

RAISR4D Substance Use Disorders

A Meta-analysis of Functional Brain Activity During Valence Processing in Internet Gaming Disorder and Gambling Disorder

Neurosci Biobehav Rev. 2026 Aug 26:106934. doi: 10.1016/j.neubiorev.2026.106934. Online ahead of print.ABSTRACTThe intersection of gaming and gambling has gained increasing attention due to their role...

RAISR4D Substance Use Disorders

From neuroinflammation to synaptic rewiring: HMGB1 as a central integrator in methamphetamine addiction

Brain Behav Immun. 2026 Aug 26:106984. doi: 10.1016/j.bbi.2026.106984. Online ahead of print.NO ABSTRACTPMID:42648456 | DOI:10.1016/j.bbi.2026.106984

RAISR4D Substance Use Disorders

Visit-level clinical correlates of next-visit heroin-positive urine in methadone maintenance treatment: A repeated-events analysis from Taiwan

J Subst Use Addict Treat. 2026 Aug 26:210098. doi: 10.1016/j.josat.2026.210098. Online ahead of print.ABSTRACTINTRODUCTION: Clinicians providing methadone maintenance treatment (MMT) care must repeatedly decide, at...

RAISR4D Substance Use Disorders

Internet gaming disorder risk in Brazil: Prevalence and associations with depressive and anxiety symptoms in a nationally representative survey

Addict Behav. 2026 Aug 22;184:108841. doi: 10.1016/j.addbeh.2026.108841. Online ahead of print.ABSTRACTINTRODUCTION: Problematic gaming is recognized in both major diagnostic systems, as Internet Gaming Disorder (IGD)...

RAISR4D Substance Use Disorders

Sexualised drug use and associations with addictive behaviors in a broad sample of Canadian adults: A mixed-methods study

Addict Behav. 2026 Aug 23;184:108842. doi: 10.1016/j.addbeh.2026.108842. Online ahead of print.ABSTRACTSexualised drug use (SDU) is the intentional use of psychoactive substances to enhance sexual experiences....

RAISR4D Substance Use Disorders

Maximizing Opioid Restitution Funds via a Networked Care Approach: The Baltimore Comprehensive Overdose Response to End the Epidemic (BCORE) Program

J Addict Med. 2026 Aug 25. doi: 10.1097/ADM.0000000000001768. Online ahead of print.ABSTRACTOpioid use disorder and overdose are significant public health crises. Treatments for opioid overdose...

RAISR4D Substance Use Disorders

Raising the Bar for Withdrawal Management: A Patient Centered Path Forward

J Addict Med. 2026 Aug 25. doi: 10.1097/ADM.0000000000001767. Online ahead of print.ABSTRACTManaging substance withdrawal is often a necessary part of addiction care. However, without treatment...

RAISR4D Substance Use Disorders

Removal of ASAM 4th Edition Withdrawal Management Standards: Implementation Risks

J Addict Med. 2026 Aug 25. doi: 10.1097/ADM.0000000000001763. Online ahead of print.ABSTRACTThe release of the ASAM criteria 4th edition marks a paradigm shift by removing...

RAISR4D Substance Use Disorders

The Storm After the Calm: A Case of Medetomidine Withdrawal

R I Med J (2013). 2026 Sep 1;109(9):53-55.ABSTRACTWe report a case of a 30-year-old woman with a history of intravenous drug use, who presented to...

RAISR4D Substance Use Disorders

Every Step Counts: Honoring Recovery in All Its Forms

R I Med J (2013). 2026 Sep 1;109(9):50-51.NO ABSTRACTPMID:42647838

RAISR4D Substance Use Disorders

Factors Associated With Victorian Adolescents’ Harm Perceptions and Attitudes About e-Cigarettes

Health Promot J Austr. 2026 Oct;37(4):e70240. doi: 10.1002/hpja.70240.ABSTRACTISSUE ADDRESSED: To explore Australian adolescents' perceptions of the risks and health harms associated with vaping and their...

RAISR4D Substance Use Disorders

Integrating Smoking Cessation With Lung Cancer Screening in Aotearoa New Zealand: Equity Considerations and Implications for Policy Development

Drug Alcohol Rev. 2026 Sep;45(6):e70245. doi: 10.1111/dar.70245.ABSTRACTInternational evidence increasingly supports integrating smoking cessation services within lung cancer screening programs, yet limited guidance exists for Aotearoa...

RAISR4D Substance Use Disorders

Measured and modelled nicotine emissions predict systemic nicotine exposure across sub-ohm and pod-based ENDS

Tob Control. 2026 Aug 25:tc-2025-060007. doi: 10.1136/tc-2025-060007. Online ahead of print.ABSTRACTBACKGROUND: Electronic nicotine delivery systems (ENDS) can deliver nicotine at levels that rival or exceed...

RAISR4D Substance Use Disorders

A Clinical Call to Action -How Developmental Translational Neuroscience can Catalyze Adolescent Substance Use Treatment: The Example of ADAPT

Neurosci Biobehav Rev. 2026 Aug 25:106935. doi: 10.1016/j.neubiorev.2026.106935. Online ahead of print.ABSTRACTAs the field more actively recognizes the unique facets of adolescent neural, social, and...

RAISR4D Substance Use Disorders

Suzetrigine (Journavx) for Acute Dental Pain: First Clinical Case Series of a Selective Naᵥ1.8 Inhibitor in Endodontics

J Endod. 2026 Aug 25:S0099-2399(26)00434-6. doi: 10.1016/j.joen.2026.08.013. Online ahead of print.ABSTRACTINTRODUCTION: Emergency dental pain remains a significant clinical challenge, with many patients experiencing moderate-to-severe pain...

RAISR4D Substance Use Disorders

Expert recommendations for training peer workers to provide non-abstinent recovery support: A real-time Delphi study

J Subst Use Addict Treat. 2026 Aug 25:210097. doi: 10.1016/j.josat.2026.210097. Online ahead of print.ABSTRACTINTRODUCTION: Peer workers-nonclinical service providers with lived experience of recovery-are a growing...

RAISR4D Substance Use Disorders

Innovations in plans of safe care implementation for infants with prenatal substance exposure

J Subst Use Addict Treat. 2026 Aug 25:210102. doi: 10.1016/j.josat.2026.210102. Online ahead of print.ABSTRACTINTRODUCTION: Federal legislation requires states to notify child welfare agencies of all...

RAISR4D Substance Use Disorders

Patient preferences for medications to treat opioid use disorder in carceral settings: Implications for tailored implementation and service delivery

J Subst Use Addict Treat. 2026 Aug 25:210099. doi: 10.1016/j.josat.2026.210099. Online ahead of print.ABSTRACTBACKGROUND: A critical lack of knowledge exists about incarcerated individuals' preferences for...

RAISR4D Substance Use Disorders

Adverse events reported to FDA adverse event reporting system for long-acting injectable buprenorphine during the first 18 months postlaunch

J Subst Use Addict Treat. 2026 Aug 25:210095. doi: 10.1016/j.josat.2026.210095. Online ahead of print.ABSTRACTINTRODUCTION: Once-monthly (Sublocade®, BUP-SB) and weekly and monthly (Brixadi®, BUP-BX) long-acting injectable...

RAISR4D Substance Use Disorders

Loneliness, connection, and personal networks among perinatal individuals with opioid use disorder: A convergent parallel mixed methods study

J Subst Use Addict Treat. 2026 Aug 25:210094. doi: 10.1016/j.josat.2026.210094. Online ahead of print.ABSTRACTLoneliness is highly pervasive among women with opioid use disorder (OUD). Emerging...

RAISR4D Substance Use Disorders

Active powerlessness: A paradox at the heart of addiction recovery

J Subst Use Addict Treat. 2026 Aug 25:210101. doi: 10.1016/j.josat.2026.210101. Online ahead of print.ABSTRACTBACKGROUND: The concept of powerlessness is central to the addiction and recovery...

RAISR4D Substance Use Disorders

Concurrent downregulation of TAAR1 and NQO1 in individuals with isolated methamphetamine use: Implications for dopaminergic and oxidative stress-related biology

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Aug 25:111904. doi: 10.1016/j.pnpbp.2026.111904. Online ahead of print.ABSTRACTBACKGROUND: Methamphetamine use disorder (MUD) is associated with profound neurobiological alterations involving dopaminergic...

RAISR4D Substance Use Disorders

Is the tobacco industry reinventing itself?

Pneumologie. 2026 Aug 25. doi: 10.1055/a-2847-7259. Online ahead of print.ABSTRACTThe tobacco industry has repeatedly adjusted its product strategy in the past. As soon as the...

RAISR4D Substance Use Disorders

Purine-centred fused, conformationally constrained, and ring-expanded analogues in antitumor and antiviral drug discovery: A comprehensive review

Eur J Med Chem. 2026 Aug 21;319:119262. doi: 10.1016/j.ejmech.2026.119262. Online ahead of print.ABSTRACTPurine-derived scaffolds remain important in anticancer and antiviral drug discovery because their electronic...

RAISR4D Substance Use Disorders

Understanding the Reproductive Life Planning Experiences of People With Disabilities in Ontario, Canada: A Qualitative Exploration

Perspect Sex Reprod Health. 2026 Aug 21. doi: 10.1111/psrh.70079. Online ahead of print.ABSTRACTINTRODUCTION: Reproductive life planning can be a valuable component of reproductive health promotion....

RAISR4D Substance Use Disorders

Implementing Group Clinical Supervision for Mental Health Nurses in Acute Adult Inpatient Wards. A Qualitative Descriptive Study

Int J Ment Health Nurs. 2026 Aug;35(4):e70336. doi: 10.1111/inm.70336.ABSTRACTClinical supervision for health care workers is well established across many disciplines; however, supervision for nurses has...

RAISR4D Substance Use Disorders

Validity and reliability of a targeted nutrition-risk screening tool for mental health services

Am J Clin Nutr. 2026 Aug 21:101489. doi: 10.1016/j.ajcnut.2026.101489. Online ahead of print.ABSTRACTAIM: To evaluate the measurement properties of a targeted nutrition-risk screening tool developed...

RAISR4D Substance Use Disorders

Aesthetic mediation and lateral agency: Rethinking trauma and drug consumption in ‘crisis ordinariness’

Int J Drug Policy. 2026 Aug 21;156:105471. doi: 10.1016/j.drugpo.2026.105471. Online ahead of print.ABSTRACTTrauma has a become a dominant causal explanation in psychological and public health...

RAISR4D Substance Use Disorders

Generalized anxiety disorder is associated with self-reported injury history among Brazilian ultramarathoners

Acta Psychol (Amst). 2026 Aug 21;270:107662. doi: 10.1016/j.actpsy.2026.107662. Online ahead of print.ABSTRACTInjuries among ultramarathoners are influenced by training load, recovery characteristics, anthropometric, and biomechanical characteristics....

RAISR4D Substance Use Disorders

Post-traumatic stress disorder (PTSD) randomized clinical trials: predicting sex differences in enrollment patterns

Psychiatry Res. 2026 Aug 17;365:117404. doi: 10.1016/j.psychres.2026.117404. Online ahead of print.ABSTRACTBACKGROUND: Equality in clinical trial enrollment by sex is important for detecting sex-specific differences in...

RAISR4D Substance Use Disorders

Bidirectional associations between pain and e-cigarette use among young adults using data from PATH Waves 7 and 7.5

Addict Behav. 2026 Aug 19;184:108839. doi: 10.1016/j.addbeh.2026.108839. Online ahead of print.ABSTRACTBACKGROUND: E-cigarette use and pain commonly co-occur in young adulthood, yet little is known about...

RAISR4D Substance Use Disorders